Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 5434-21-9 | MDL No. : | MFCD00013985 |
Formula : | C8H7NO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | OXSANYRLJHSQEP-UHFFFAOYSA-N |
M.W : | 181.15 | Pubchem ID : | 72912 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 3.0 |
Molar Refractivity : | 44.76 |
TPSA : | 100.62 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.16 cm/s |
Log Po/w (iLOGP) : | 0.31 |
Log Po/w (XLOGP3) : | 0.34 |
Log Po/w (WLOGP) : | 0.67 |
Log Po/w (MLOGP) : | -0.47 |
Log Po/w (SILICOS-IT) : | -0.09 |
Consensus Log Po/w : | 0.15 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -1.39 |
Solubility : | 7.43 mg/ml ; 0.041 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.02 |
Solubility : | 1.74 mg/ml ; 0.00962 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -0.79 |
Solubility : | 29.7 mg/ml ; 0.164 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.26 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96% | With hydrogen In ethanol at 20℃; for 3 h; | 1 g (4.73 mmol) of 4-nitrophthalic acid is dissolved in 10 ml of anhydrous ethanol. The solution is stirred at room temperature and degassed under argon. 50 mg of 5percent palladium/carbon are added all at once and hydrogen is bubbled through the solution. After 3 hours, the solution is filtered on celite and then evaporated. [00347] Orange-coloured oil. m=820 mg. Y=96percent. 1H NMR (DMSO): 3.32 (1H, s), 5.95 (1H, s), 6.49-6.53 (2H, m), 7.46-7.50 (1H, d, J=8.8 Hz), 12.33 (2H, COOH, s). |
96% | With hydrogen In ethanol at 20℃; for 3 h; | 1 g (4.73 mmol) of 4-nitrophthalic acid is dissolved in 10 mL of anhydrous ethanol. The solution is stirred at room temperature and degassed under argon. 50 mg of palladium/charcoal (5percent) are added in a single portion and hydrogen is bubbled into the solution. After 3 hours, the solution is filtered through Celite and then evaporated. [00137] Orange-coloured oil. m=820 mg. Y=96percent. 1H NMR (DMSO): 3.32 (1H, s), 5.95 (1H, s), 6.49-6.53 (2H, m), 7.46-7.50 (1H, d, J=8.8 Hz), 12.33 (2H, COOH, s). |
[ 21339-73-1 ]
4-Amino-2,5-dimethylbenzoic acid
Similarity: 0.98
[ 5628-44-4 ]
4-Amino-2,3-dimethylbenzoic acid
Similarity: 0.91
[ 21339-73-1 ]
4-Amino-2,5-dimethylbenzoic acid
Similarity: 0.98
[ 5628-44-4 ]
4-Amino-2,3-dimethylbenzoic acid
Similarity: 0.91
[ 21339-73-1 ]
4-Amino-2,5-dimethylbenzoic acid
Similarity: 0.98
[ 5628-44-4 ]
4-Amino-2,3-dimethylbenzoic acid
Similarity: 0.91